Outset Medical Company Leadership
OM Stock | USD 17.74 0.23 1.31% |
Outset Medical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Outset Medical stock suggests that most insiders are panicking at this time. Outset Medical employs about 354 people. The company is managed by 20 executives with a total tenure of roughly 826 years, averaging almost 41.0 years of service per executive, having 17.7 employees per reported executive.
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-05-15 | John L Brottem | Disposed 396 @ 17.82 | View | ||
2025-02-18 | Marc Nash | Disposed 280 @ 13.5 | View | ||
2025-01-21 | Nabeel Ahmed | Disposed 2285 @ 12 | View | ||
2025-01-13 | John L Brottem | Disposed 1366 @ 12.15 | View | ||
2025-01-07 | Nabeel Ahmed | Disposed 122 @ 19.35 | View | ||
2024-11-15 | John L Brottem | Disposed 213 @ 12 | View |
Monitoring Outset Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. Outset Medical's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Outset Medical's future performance. Based on our forecasts, it is anticipated that Outset will maintain a workforce of about 350 employees by August 2025.Outset Medical Management Team Effectiveness
The company has Return on Asset (ROA) of (0.1741) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1741. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.8653) %, which implies that it produced no returns to current stockholders. Outset Medical's management efficiency ratios could be used to measure how well Outset Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of July 2025, Return On Tangible Assets is likely to drop to -0.49. In addition to that, Return On Capital Employed is likely to drop to -0.52. At this time, Outset Medical's Debt To Assets are very stable compared to the past year. As of the 22nd of July 2025, Fixed Asset Turnover is likely to grow to 9.89, while Return On Tangible Assets are likely to drop (0.49).As of the 22nd of July 2025, Common Stock Shares Outstanding is likely to drop to about 3.1 M. In addition to that, Net Loss is likely to drop to about (154 M)
Outset Medical Workforce Comparison
Outset Medical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 6,382. Outset Medical holds roughly 354 in number of employees claiming about 6% of equities under Health Care industry.
The company has Net Profit Margin (PM) of (0.99) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.55) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.55. Outset Medical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Outset Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Outset Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Outset Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-06-01 | 2.75 | 11 | 4 | 331,230 | 2,167 |
2025-03-01 | 0.6 | 18 | 30 | 4,358,288 | 308,284 |
2024-06-01 | 0.9 | 9 | 10 | 244,303 | 139,519 |
2024-03-01 | 1.0 | 23 | 23 | 1,783,909 | 140,663 |
2023-09-01 | 0.2381 | 5 | 21 | 47,753 | 134,462 |
2023-06-01 | 0.6087 | 14 | 23 | 118,010 | 140,162 |
2023-03-01 | 0.5333 | 24 | 45 | 554,535 | 290,491 |
2022-12-01 | 0.36 | 9 | 25 | 95,261 | 169,990 |
2022-09-01 | 0.1333 | 2 | 15 | 35,000 | 108,966 |
2022-06-01 | 0.5128 | 20 | 39 | 190,432 | 361,860 |
2022-03-01 | 0.8049 | 33 | 41 | 368,886 | 273,147 |
2021-12-01 | 0.3958 | 19 | 48 | 137,762 | 349,936 |
2021-09-01 | 0.5263 | 30 | 57 | 194,117 | 353,380 |
2021-06-01 | 0.58 | 29 | 50 | 277,180 | 8,154,892 |
2021-03-01 | 1.7 | 17 | 10 | 398,284 | 1,146,322 |
2020-12-01 | 0.4 | 2 | 5 | 90,000 | 7,372,450 |
2020-09-01 | 0.25 | 10 | 40 | 12,899,301 | 120,135,462 |
Outset Medical Notable Stakeholders
An Outset Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Outset Medical often face trade-offs trying to please all of them. Outset Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Outset Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Leslie Trigg | CEO President | Profile | |
Renee Gaeta | Principal CFO | Profile | |
Amelia Merrill | VP Culture | Profile | |
John Geraci | VP Controller | Profile | |
Laura Romike | Senior Sales | Profile | |
Jennifer Sipple | Senior Experience | Profile | |
Stacey Porter | Chief Officer | Profile | |
Mark MS | Chief Officer | Profile | |
Steven Williamson | Chief Officer | Profile | |
Marc Nash | Senior RD | Profile | |
John JD | General Secretary | Profile | |
Dinamarie Stefani | Senior Assurance | Profile | |
Martin Vazquez | Chief Officer | Profile | |
John Brottem | General Secretary | Profile | |
JeanOlivier Racine | Chief Officer | Profile | |
James Mazzola | Head Relations | Profile | |
Michael MD | Chief Officer | Profile | |
Nicole Shannon | Director Communications | Profile | |
Tonya Saffer | Head Access | Profile | |
Nabeel Ahmed | Principal CFO | Profile |
About Outset Medical Management Performance
The success or failure of an entity such as Outset Medical often depends on how effective the management is. Outset Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Outset management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Outset management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.46) | (0.49) | |
Return On Capital Employed | (0.49) | (0.52) | |
Return On Assets | (0.46) | (0.49) | |
Return On Equity | (4.77) | (4.53) |
Outset Medical Workforce Analysis
Traditionally, organizations such as Outset Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Outset Medical within its industry.Outset Medical Manpower Efficiency
Return on Outset Medical Manpower
Revenue Per Employee | 321.2K | |
Revenue Per Executive | 5.7M | |
Net Loss Per Employee | 361.5K | |
Net Loss Per Executive | 6.4M | |
Working Capital Per Employee | 601.3K | |
Working Capital Per Executive | 10.6M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (28.79) | Revenue Per Share | Quarterly Revenue Growth 0.056 | Return On Assets | Return On Equity |
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Outset Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.